Roivant Sciences Ltd.
(ROIV)
undefined
undefined%
At close: undefined
11.36
-1.26%
Pre-market Jan 07, 2025, 04:00 AM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | 4.23B | -1.12B | -924.12M | -900.23M | -519.39M |
| Depreciation & Amortization | 22.04M | 18.86M | 5.93M | n/a | n/a |
| Stock-Based Compensation | 199.63M | 217.78M | 564.96M | 84.96M | n/a |
| Other Working Capital | -3.65M | 1.99M | 316.00K | 68.19M | 8.70M |
| Other Non-Cash Items | -5.24B | 29.09M | -340.22M | 191.20M | -257.73M |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | 19.04M | 6.34M | 15.72M | 71.94M | 15.30M |
| Operating Cash Flow | -765.27M | -843.39M | -677.73M | -552.14M | -761.83M |
| Capital Expenditures | -1.38M | -12.69M | -17.44M | -5.81M | -4.92M |
| Acquisitions | -36.98M | 107.86M | -39.00K | n/a | 1.77B |
| Purchase of Investments | n/a | n/a | n/a | n/a | -68.38M |
| Sales Maturities Of Investments | n/a | n/a | 320.17M | n/a | 16.44M |
| Other Investing Acitivies | 5.24B | -139.43M | 600.00K | -25.90M | -20.05M |
| Investing Cash Flow | 5.20B | -44.27M | 303.30M | -31.70M | 1.69B |
| Debt Repayment | -30.70M | 129.75M | 14.81M | n/a | -32.06M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | -1.19B |
| Dividend Paid | -6.00M | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 17.51M | -10.00M | 291.98M | 508.00K | 83.48M |
| Financial Cash Flow | 419.36M | 499.46M | 306.79M | 456.26M | 217.16M |
| Net Cash Flow | 4.86B | -381.92M | -67.64M | -127.58M | n/a |
| Free Cash Flow | -766.65M | -856.08M | -695.16M | -557.94M | -766.75M |